Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMH as Ovarian Reserve Marker in Breast Cancer
NCT02113553Phase 2Terminated
- Sponsor
- Armando Santoro
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in breast cancer, sponsored by Armando Santoro. Started May 2013; status: terminated.
02
Drugs
triptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02113553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113553.